Cheryl Hemingway has been a Consultant Paediatric Neurologist at Great Ormond Street Hospital for Children (GOSH) in London for over 20 years. She has worked and trained in paediatric neurology at Red Cross, South Africa; Johns Hopkins, USA and the John Radcliffe Hospital, Oxford. Her PhD from Imperial College used RNA array technology to explore the host immune response to brain inflammation, and she has used the expertise gained from this to provide specialised clinical care to children with rare acquired neuroinflammatory disorders.

She leads the GOSH Neuroinflammatory Disease service, the largest clinic in the UK for children with Multiple Sclerosis, MOGAD and other rare demyelinating and neuroinflammatory disorders, as well as being Lead for the Inherited White Matter Disorders Service. She is research active, is an Ass Prof at the Institute of Child Health, University College London (UCL) and has a number of recent important publications. She is PI and Co-PI at GOSH on a number of acquired and inherited white matter trials. She is Chair of the International Pediatric MS Study Group and sits on advisory panels for both MS and MOGAD trial design.